PBM: Peri-op care
· Pre-op anaemia investigations
· Pre-op anaemia treatment
· Pre-op haemostasis tests
· Pre-op anti-haemostatic cessation
· Intra-op pro-haemostatics
· Autologous blood transfusion
Haemoglobin |
<130 men <120 women |
Mean cell volume |
Small = IDA Normal = chronic disease Large = haematinics |
Ferritin |
<30 iron deficient 30-100 maybe iron deficient |
Transferrin saturation |
<20% iron deficient |
Haematinics |
B12, RBC, rolate |
Haemopoiesis |
Creat LFT TFT Physician review |
Blood loss |
Gastroscopy + colonoscopy |
Iron deficiency |
IV iron 4/52 pre-op Aim ferritin >100 |
Chronic disease |
IV iron +/- Epo Aim Hb 100-115 |
Haematinic deficiency |
B12 Folate |
Platelets |
>50: likely ok for invasive procedure (>100 if brain, eye, neuraxis) |
INR |
<2L likely ok for invasive procedure (not if brain, eye, neuraxis) |
Aspirin |
Cardiac: withhold on day of surgery Neuro and eye: consider ceasing pre-op 7-10 days (?) |
Clopidogrel |
Cardiac: cease ≥5/7 pre-op If more important: maybe continue (DES 12/12, BMS 6/52, recent stroke) If less important: cease 7-10 days pre-op |
NSAIDs |
Ortho: cease pre-op (time varies) |
Warfarin |
Continue if: scopes without intervention, cataract, minor dental Reversal: see American College of Chest Physicians or Australasian Society of Thrombosis and Haemostasis |
TXA |
Use if expecting significant loss |
EACA |
Use if expecting significant loss Not available in Aus and NZ |
Aprotinin |
Removed from the market Risk of renal failure and death |
Desmopressin |
Use if vWD type 1 or 2a (?) Not for routine use Risk of stroke and death |
Autologous donation |
Reduces risk of allogeneic transfusion Increases risk of any blood transfusion Routine use not recommended |
Acute normovolaemic haemodilution |
Use if a) health Hb b) expecting significant loss Need a local protocol |
Intra-op cell saver |
Use if expecting significant loss intra-op (e.g. AAA) Need a local protocol |
Post-op cell saver |
Use if expecting significant loss post-op (e.g. TKR) Need a local protocol |
Cardiac surgery |
No routine FFP No routine platelets |
Liver disease |
No routine FFP for ↑INR |
Prophylactic F7a |
Risk of thrombotic events |
Epo |
Not if PHx cancer (-> recurrence) Not if active cancer (-> stroke, death) Not a replacement for iron |